Fibroblast growth factors (FGF) are con stantly present in normal central nervous tis sues such as the brain (1) and pituitary (2); however, neovascularization and proliferation of endothelial cells in these tissues are very low (3). Therefore, it has been suspected that the onset of FGF action in central nervous tis sues is negatively controlled by some com ponents. Folkman et al. have indicated that basic FGF (FGFb) activity is masked by its binding to heparan sulfate localized in the basement membrane of the bovine cornea (4). Heparin is known to inhibit FGFb activity during endothelial cell proliferation in vitro (5). In contrast to these macromolecular in hibitors, low molecular weight substances, such as corticoids (6) and endothelial cell stimulating angiogenesis factor (ESAF) (7), have been reported to stimulate endothelial cell proliferation in response to FGF. Very recently, we demonstrated that FG F-action on porcine aortic endothelial cell (PAEC) growth was largely retarded when the cells were in cubated in Dulbecco's modified Eagle's medi um (DMEM) supplemented with 1% fetal bovine serum (FBS) or 10% dialyzed FBS (8). Using this model, we have attempted to identify stimulatory or inhibitory effectors of PAEC growth, particularly in response to FGF, from the bovine brain dialyzable fraction.
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Materials and Methods Cell culture
Porcine aortic endothelial cells (PAEC) were isolated and grown as described (9). Briefly, the PAEC were grown in DMEM con taining 10% FBS and subcultured into a 25 cm2 culture flask with a 0.25% trypsin solution containing 0.02% ethylenediaminetetraacetic acid (EDTA) when the cells reached con fluence. Generally, cells from passages 8 to 12 were used for testing purposes. In the cells cultured in 1% FBS or 10% dialyzed FBS, the percentage of non-viable cells was less than 5%. Thymidine incorporation assay Cells (1 X 104/cm2) were seeded in 48-well (Costar) tissue culture plates and then in cubated for 32 hr in 500 ill of media con taining 10% FBS to allow for attachment. The medium was then replaced with fresh DMEM containing 1 % FBS with or without bovine brain dialyzable fraction or its extract, and/or an aliquot of acidic FGF (FGFa) plus heparin or FGFb. After incubating for 16 hr, all the wells were pulsed for 8 hr with 0.1 ,uCi of [3H]thymidine (10 flM) per well. The cells were then washed with cold phosphate-buf fered saline and solubilized with 0.2 ml of 0.25 M NaOH.
[3H]Thymidine-incorporated DNA was precipitated with 10% trichloroace tic acid. The resulting precipitates were col lected on glass filters (GF/F, Whatman), and the filters were washed with 10%trichloroace tic acid and ethanol. Radioactivity on the filter was counted by a liquid scintillation counter using 5 ml of toluene containing 0.5% 2,5-diphenyloxazole.
Rate of proliferation assay
For measuring the number of viable cells, PAEC (4X104) were grown in 6-well (9.6 cm2) tissue culture plates (Becton Dickinson Lab., U.S.A.). After incubating for various times, the number of detached cells was counted with a hemocytometer in a trypsin (0.25%) EDTA (0.02%) solution following staining with 0.05% nigrosine solution in saline. Replicate wells in the same dish were generally examined for any of the given test conditions. Purification of hypoxanthine and inosine from dialyzable fraction of bovine homo genates Preparation of dialyzable fraction of bovine brain homogenates:
Fresh bovine brains (470 g) were homogenized in 470 ml of cold H20 with a Waring blender at 4°C. Homogenates were dialyzed against 15 volumes (v/v) of cold H20 for 18 hr. Dialyzable fractions ob tained were concentrated by a freeze-dry meth od, and aliquots were adjusted by dissolving in distilled water so that 1 /d of the dialyzable fraction was derived from 1 mg of brain tissue (referred to as the bovine brain dialyzable fraction).
Isolation of active compounds from di alyzable fraction: The bovine brain dialyzable fraction was adjusted to pH 12 with 5 M NaOH and stirred with Dowex 1 x8 (0H form) resin (56 ml in volume). After washing with 10 mM NaOH (100 ml), the resin was adjusted to pH 2.0 with aliquots of 1 M HCI, and packed in a column (3x8 cm). Then the column was rinsed with 10 mM HCI. The growth-promoting activity eluted in fractions was assayed by [3H]thymidine incorporation into DNA. The active fractions were com bined and mixed with 5 g of silica gel (Merck, Kieselgel 60, 70-230 mesh). The gel sus pension was evaporated and suspended in acetone. The acetone suspension was layered on top of fresh silica gel (26.6 ml in volume) in a column (2.2X10 cm). The activity for [3H] DNA synthesis was eluted from the gel with 200 ml of a mixture of acetone : water (9:1, v/v), combined, and evaporated. The yield of the active compound was approximately 126 mg, which was readsorbed on to 0.50 g of silica gel and rechromatographed (1.3X10 cm). Two peaks of [3H] DNA synthesis ac tivity were eluted with a mixture of chloro form : methanol : water (4:2:1, v/v, a bottom phase). Pure active compound, 17.2 mg, was recovered from several fractions in the first peak, which was crystallized from hot water. Since the active fractions of the second peak (20.5 mg) were highly contaminated with the first peak component, they were combined and mixed with 0.2 g silica gel. After evaporat ing, the gel powder was layered on top of a fresh silica gel column (1 x10.5 cm). The [3H] DNA synthetic activity was eluted from the gel with a mixture of chloroform : meth anol : water (10:5:1, v/v). The yield of pure active component from the second peak was 4.09 mg, which was crystallized from hot water. The purity of each compound was checked by thin layer chromatography (TLC) on Kieselgel 60 F254 plates (0.25 mm thick ness) using a solvent system of chloroform : methanol : water (4:2:1, v/v, a bottom phase), and by high-performance liquid chromatography (HPLC) on an SC-02 col umn (JASCO, Japan) using a methanol gradient of 0 to 40% in 0.02 M potassium phosphate buffer (pH 5.6). The active com pounds on TLC plates were routinely visu alized using three methods: 1) fluorescence quenching, 2) iodine adsorption, and 3) reac tion with ninhydrin. Each spot visualized by these methods on plates was scrapped off and washed with aliquots of H20 to extract the components.
Identification of chemical nature of active components:
Identification of pure active fractions was conducted by the following methods : ' H and 13C-nuclear magnetic re sonance (N M R) spectra were recorded on a JNM-FX200 spectrometer (JEOL, Japan). NMR spectra were taken as 1-2% w/v solu tions in dimethylsulfoxide-d6 (99.8%) at 260C with tetramethylsilane as an internal reference. Infrared spectra were recorded with a Shi madzu I R-400 spectrophotometer.
Electron impact and field desorption mass spectra were taken on a JMS-01 S6-2 spectrometer (JEOL, Japan).
Statistical analysis
Student's t-test was used to determine the significance of the difference between groups (10).
Chemicals and reagents
The chemicals and reagents used were ob tained from the following sources: Dulbecco's modified Eagle's medium ,"Nissui" from Nissui Pharmaceutical Co., Ltd. ( heparin and other reagents of the highest available quality were obtained from commercial sources. Fig. 1 . Effect of the bovine brain dialyzable fraction on the rate of proliferation of PAEC. PAEC 4x104/ 2.0 ml) were seeded into each well (9.6 cm2) and preincubated at 37'C for 24 hr. Then, at day 0, media were replaced with 2.0 ml of fresh media containing 1% FBS (0), 10% FBS (0) or 10% dialyzed FBS (A) in the presence (closed symbol) or absence (open symbol) of 1% (v/v) of the bovine brain dialyzable fraction. The cells were allowed to pro liferate at 37°C for a further 2, 4 or 7 days. Media were changed every other day with the respective fresh ones. After incubation, the cells were detached by trypsinization and suspended in 0.05% nigrosine solution to count viable cell numbers with a hemocy tometer. Each value is the mean of two samples,
Results
Effect of bovine brain dialyzable fraction on the rate of proliferation of PAEC: In media with 11% FBS or 10% dialyzed FBS, the num ber of growing PAEC decreased markedly as compared with that in the regular media con taining 10% FBS. This cell growth retardation was found to be mostly overcome by the ad dition of 1 % of the bovine brain dialyzable fraction into each media (Fig. 1) by increasing the amount of the bovine brain dialyzable fraction (Fig. 2) the presence of FGFa plus heparin (Fig. 3A) or FGFb (Fig. 3B) .
Purification of hypoxanthine and inosine as active components from bovine brain dia lyzable fraction: The bovine dialyzable fraction was subjected to several steps of purification as described in Materials and Methods. Two active components (compounds 1 and 2) for stimulating the [3H] DNA synthesis of PAEC were fractionated by means of silica gel chromatography.
Compounds 1 and 2 were identified to be hypoxanthine and inosine, re spectively, from the results of their relative mobilities on TLC plates as compared with those of reference compounds (Fig. 4) . Tables 1, 2 All analytical data for compounds 1 and 2 were assigned the structures of hypo xanthine and inosine, respectively; and they were completely consistent with data of the hypoxanthine and inosine standards. (Fig. 5) . Maximal growth of FGF-stimulated PAEC was obtained when 5 /iM of hypoxanthine or inosine was sup plemented into the media. However, no ad ditive effect was observed on [3H]thymidine incorporation into DNA of PAEC in 1 % FBS media with or without FGF when 50 flM of hypoxanthine and inosine were added simul taneously (Fig. 6) . Table 3 .
Physico-chemical properties of compounds 1 and 2
Discussion
The present report shows that PAEC do not proliferate well in response to FGF in either dialyzed serum media or low serum media, and that proliferation of PAEC in low serum media in response to FGF can be enhanced to a level of media containing 10% FBS by addition of the brain dialyzable fraction. Active com ponents of the dialyzable fraction were found to be hypoxanthine or inosine.
Although hypoxanthine and inosine both were demonstrated to be active in the stimula tion of [3H] DNA synthesis in PAEC in low serum media, their action mechanism may be not so different from each other, because the maximum stimulation by hypoxanthine was not further enhanced by addition of an excess amount of inosine, and vice versa (Fig. 6) . Inosine is hydrolyzed to yield its purine base hypoxanthine and D-ribose, whereas hypo xanthine is salvaged in conjunction with 5 phosphoribosyl-1 -pyrophosphate (PRPP) to yield inosic acid by hypoxanthine-guanine phosphoribosyltransferase.
Therefore, inosine may be hydrolyzed to hypoxanthine prior to being salvaged through this enzyme action, because free purines formed on degradation of purine nucleotides are in large part salvaged and used over again to remake nucleotides. Since FGFb was reported to stimulate the formation of PRPP in fibroblasts (11 ), it might be available for FGF-stimulated endothelial cells to reassemble purine nucleotides via the salvage pathway in PAEC in low serum media. However, there is less information about the metabolism of hypoxanthine, inosine or PRPP in PAEC in low serum media with or without FGF.
The bovine brain dialyzable fraction, hy poxanthine or inosine, mildly stimulated the [3H] DNA synthesis of PAEC in low serum media in the absence of FGF (Figs. 3 and 5 ). This basal stimulation may be caused by the residual FGF in 1% FBS, because bovine serum is reported to contain approximately 200 ng/ml of immunoreactive FGF (12). On the other hand, the bovine brain dialyzable fraction did not induce more growth-promot ing activity in PAEC cultured in 10% FBS in place of 1 % FBS or 10% dialyzed FBS. If we assume hypoxanthine is an essential com ponent in both basal and FGF-stimulated growth of PAEC, this result indicates that 10% FBS might contain a sufficient quantity of hypoxanthine. In fact, a high concentration of hypoxanthine, about 75 jiM, was reported in FBS (13), in contrast to a much lower level (1-2.5 jM) of hypoxanthine in bovine serum (13) and human plasma (14). Subsequently, the regular medium with 10% FBS contained more than 5 iM of hypoxanthine, and this concentration corresponded with the dose that produced maximal stimulation of [3H] thymidine incorporation into DNA of PAEC (Fig. 5) .
Furthermore, it is noteworthy that both hypoxanthine levels are high in tissues in which angiogenesis occurs such as ovarian follicle (15), placenta (16) , wound sites (17) , and tumors (18) as well as ischemic brain (19) . These results including our present observation suggest that the increases in hypoxanthine and inosine levels have some thing to do with FGF-stimulated growth of endothelial cells (or angiogenesis). Of particular importance is the work of Weiss and her collaborators. They showed that endothelial cell stimulating angiogenesis factor (ESAF), molecular mass of <600 (20) , potentiates the activity of FGF (7). Although the chemical nature of ESAF has not been determined, ESAF, in contrast to hypoxan thine, stimulated capillary endothelial cell growth, but not aortic endothelial cell growth (21 ) . Furthermore, ESAF activated mam malian procollagenase (22) , while hypoxan thine did not have such activity (Y. Hayashi et al., unpublished data). Therefore, we suspect that ESAF differs from the character istics of hypoxanthine with regard to its biological activity.
Hypoxanthine has been reported to have various biological activities such as stimula tion of DNA synthesis in serum-starved L cells (23) and neuroblasts (24) , stimulation of differentiation of erythroleukemia cells (25, 26) , and maintenance of murine oocyte meiotic arrest (15), and enhancement of cel lular immunity (27) . Besides these actions, we present here that hypoxanthine and inosine have an effect on FGF-dependent proliferation of PAEC grown in a serum-limited culture system.
